Analyst Ratings for Celldex Therapeutics (CLDX)
CLDX Rating Summary
CLDX Price Target Summary
- Highest: $67.00 (Cantor Fitzgerald)
- Lowest: $24.00 (Barclays)
- Average: $46.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$46.50 (+58%)
* Over Last 12-Mos
Rating Score: 7.6 / 10
Percentile Rank: 81%
Avg. $ Target:
$46.50 (+58%)
* Over Last 12-Mos
Rating Score: 7.6 / 10
Percentile Rank: 81%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/21/2025 | Mizuho | Joseph Catanzaro | New Coverage | Outperform (N/A) |
48.00 (N/A) |
26.83 (29.43) |
9.69% | Details |
| 10/13/2025 | Barclays » Updated 12/17/2025 |
Etzer Darout | New Coverage | Underweight (N/A) |
24.00 (21.00) |
27.54 (29.43) |
6.86% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
